Donald Perrier

2.2k total citations
53 papers, 1.6k citations indexed

About

Donald Perrier is a scholar working on Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and Molecular Biology. According to data from OpenAlex, Donald Perrier has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pediatrics, Perinatology and Child Health, 12 papers in Geriatrics and Gerontology and 7 papers in Molecular Biology. Recurrent topics in Donald Perrier's work include Pharmaceutical studies and practices (14 papers), Pharmaceutical Practices and Patient Outcomes (12 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Donald Perrier is often cited by papers focused on Pharmaceutical studies and practices (14 papers), Pharmaceutical Practices and Patient Outcomes (12 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Donald Perrier collaborates with scholars based in United States, Canada and New Zealand. Donald Perrier's co-authors include Milo Gibaldi, Michael Mayersohn, Peter R. Gwilt, Donald Jung, James M. Gallo, Fred C. Lam, J. Robert Powell, Linda M. Strand, Jerry M. Calkins and Gerhard Levy and has published in prestigious journals such as JAMA, Annals of Internal Medicine and The American Journal of Cardiology.

In The Last Decade

Donald Perrier

52 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald Perrier United States 23 358 341 304 216 214 53 1.6k
Renato L. Galeazzi Switzerland 16 371 1.0× 249 0.7× 243 0.8× 251 1.2× 280 1.3× 45 1.6k
Richard L. Slaughter United States 27 440 1.2× 343 1.0× 376 1.2× 214 1.0× 232 1.1× 64 1.9k
Ingegerd Odar‐Cederlöf Sweden 23 256 0.7× 390 1.1× 293 1.0× 218 1.0× 274 1.3× 53 1.7k
Michael Orme United Kingdom 28 425 1.2× 492 1.4× 670 2.2× 310 1.4× 186 0.9× 79 2.4k
Gillian M. Shenfield Australia 28 349 1.0× 322 0.9× 380 1.3× 240 1.1× 200 0.9× 114 2.3k
Sylvia M. Wallace Canada 21 272 0.8× 223 0.7× 200 0.7× 219 1.0× 177 0.8× 44 1.6k
B. Whiting United Kingdom 28 492 1.4× 460 1.3× 294 1.0× 251 1.2× 243 1.1× 100 2.3k
M. Orme United Kingdom 24 224 0.6× 408 1.2× 657 2.2× 228 1.1× 165 0.8× 55 1.7k
A Breckenridge United Kingdom 21 265 0.7× 214 0.6× 479 1.6× 184 0.9× 223 1.0× 43 1.9k
Kenneth M. Piafsky Canada 15 413 1.2× 369 1.1× 351 1.2× 263 1.2× 385 1.8× 18 1.7k

Countries citing papers authored by Donald Perrier

Since Specialization
Citations

This map shows the geographic impact of Donald Perrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald Perrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald Perrier more than expected).

Fields of papers citing papers by Donald Perrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald Perrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald Perrier. The network helps show where Donald Perrier may publish in the future.

Co-authorship network of co-authors of Donald Perrier

This figure shows the co-authorship network connecting the top 25 collaborators of Donald Perrier. A scholar is included among the top collaborators of Donald Perrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald Perrier. Donald Perrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Carrie L., et al.. (2008). Outcomes from DiabetesCARE: A pharmacist-provided diabetes management service. Journal of the American Pharmacists Association. 48(6). 722–730. 49 indexed citations
2.
Johnson, Carrie L., et al.. (2008). PharmacistCARE: Description of a pharmacist care service and lessons learned along the way. Journal of the American Pharmacists Association. 48(6). 793–802. 11 indexed citations
3.
Gallo, James M., Fred C. Lam, & Donald Perrier. (1991). Moment method for the estimation of mass transfer coefficients for physiological pharmacokinetic models. Biopharmaceutics & Drug Disposition. 12(2). 127–137. 5 indexed citations
4.
Gallo, James M., Chi Tim Hung, Pramod Gupta, & Donald Perrier. (1989). Physiological pharmacokinetie model of adriamycin delivered via magnetic albumin microspheres in the rat. Journal of Pharmacokinetics and Biopharmaceutics. 17(3). 305–326. 14 indexed citations
5.
Gallo, James M., Fred C. Lam, & Donald Perrier. (1987). Area method for the estimation of partition coefficients for physiological pharmacokinetic models. Journal of Pharmacokinetics and Biopharmaceutics. 15(3). 271–280. 73 indexed citations
6.
Elenbaas, Robert M., William E. Evans, Philip P. Gerbino, et al.. (1985). Definition of Clinical Pharmacy as a Specialty in Clinical Practice. Drug Intelligence & Clinical Pharmacy. 19(2). 149–150.
7.
Graves, Penelope E., Paul E. Fenster, R. T. MacFarland, Gregory M. Marcus, & Donald Perrier. (1984). Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in normal subjects. Clinical Pharmacology & Therapeutics. 36(5). 601–606. 6 indexed citations
8.
Martin, Robert E., et al.. (1983). A Planned Program for Evaluation and Development of Clinical Pharmacy Faculty. American Journal of Pharmaceutical Education. 47(2). 102–107. 9 indexed citations
9.
Jones, William N., et al.. (1982). Evaluation of Various Methods of Digoxin Dosing. The Journal of Clinical Pharmacology. 22(11). 543–550. 7 indexed citations
10.
Jung, Donald, et al.. (1982). Thiopental Disposition in Lean and Obese Patients Undergoing Surgery. Anesthesiology. 56(4). 269–274. 65 indexed citations
11.
Hager, W, et al.. (1981). Assessment of beta blockade with propranolol. Clinical Pharmacology & Therapeutics. 30(3). 283–290. 22 indexed citations
12.
Fenster, Paul E., Donald Perrier, Michael Mayersohn, & Gregory M. Marcus. (1980). Kinetic evaluation of the propranolol-quinidine combination. Clinical Pharmacology & Therapeutics. 27(4). 450–453. 5 indexed citations
13.
Lubawy, William C. & Donald Perrier. (1980). The effect of acute tobacco smoke exposure on pulmonary benzo[a]pyrene metabolism. Environmental Research. 21(2). 438–445. 9 indexed citations
14.
Gwilt, Peter R. & Donald Perrier. (1978). Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyzability. Clinical Pharmacology & Therapeutics. 24(2). 154–161. 59 indexed citations
15.
Kostenbauder, H.B., Robert P. Rapp, J. Patrick McGovren, et al.. (1975). Bioavailability and single‐dose pharmacokinetics of intramuscular phenytoin. Clinical Pharmacology & Therapeutics. 18(4). 449–456. 54 indexed citations
16.
Perrier, Donald & Milo Gibaldi. (1974). CLEARANCE AND BIOLOGIC HALF-LIFE AS INDICES OF INTRINSIC HEPATIC METABOLISM. Journal of Pharmacology and Experimental Therapeutics. 191(1). 17–24. 90 indexed citations
17.
Perrier, Donald & Milo Gibaldi. (1974). Drug Concentrations in the Plasma as an Index of Pharmacologic Effect. The Journal of Clinical Pharmacology. 14(8-9). 415–417. 9 indexed citations
18.
Perrier, Donald, et al.. (1974). An In vitro Pharmacokinetic System for use in the Undergraduate Pharmaceutics Laboratory. I. General Considerations. American Journal of Pharmaceutical Education. 38(4). 560–567. 1 indexed citations
19.
Kristensen, M., J. Mølholm Hansen, J. P. Kampmann, et al.. (1974). DRUG ELIMINATION AND RENAL FUNCTION. The Journal of Clinical Pharmacology. 14(5-6). 307–308. 19 indexed citations
20.
Gibaldi, Milo & Donald Perrier. (1972). Drug Distribution and Renal Failure. PubMed. 12(5-6). 201–204. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renato L. Galeazzi Breakdown of academic impact, for papers by Richard L. Slaughter Breakdown of academic impact, for papers by Ingegerd Odar‐Cederlöf Breakdown of academic impact, for papers by Michael Orme Breakdown of academic impact, for papers by Gillian M. Shenfield Breakdown of academic impact, for papers by Sylvia M. Wallace Breakdown of academic impact, for papers by B. Whiting Breakdown of academic impact, for papers by M. Orme Breakdown of academic impact, for papers by A Breckenridge Breakdown of academic impact, for papers by Kenneth M. Piafsky
Rankless by CCL
2026